23 May 2013
Keywords: novartis, alnylam, enter, rnai, avian, flu, accord
Article | 27 February 2006
Swiss drug major Novartis and the USA's Alnylam Pharmaceuticals have entered a new collaboration to develop therapeutics for pandemic flu
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 February 2006
20 February 2006
© 2013 thepharmaletter.com